Observation of Ketamine Treatment Safety and Tolerability in Adult Psychiatry Clinic Medical University of Gdańsk Inpatients

This prospective observational registry collects systematic real-world data on ketamine administration in a tertiary inpatient psychiatry service to evaluate safety, tolerability and patient-reported outcomes across diverse clinical presentations.

Treatments include slow IV infusions (0.5 mg/kg over 40 minutes), intranasal spray, and oral solution (2.0–2.5 mg/kg), administered twice weekly for 4 weeks; adverse events, vitals and longer-term outcomes are documented to inform clinical practice.